Related Experiment Video
Updated: Mar 19, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Cecropin B Represses CYP3A29 Expression through Activation of the TLR2/4-NF-κB/PXR Signaling Pathway
Xiaoqiao Zhou1, Xiaowen Li1, Xiliang Wang1
1State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, P.R. China.
Abstract:
Cecropins are peptide antibiotics used as drugs and feed additives. Cecropin B can inhibit the expression of CYP3A29, but the underlying mechanisms remain unclear. The present study was designed to determine the mechanisms responsible for the effects of cecropin B on CYP3A29 expression, focusing on the Toll-like receptors (TLRs) and NF-κB pathways. Our results indicated that the CYP3A29 expression was inhibited by cecropin B, which was regulated by pregnane X receptor (PXR) in a time- and dose-dependent manner. Cecropin B-induced NF-κB activation played a pivotal role in the suppression of CYP3A29 through disrupting the association of the PXR/retinoid X receptor alpha (RXR-α) complex with DNA sequences. NF-κB p65 directly interacted with the DNA-binding domain of PXR, suppressed its expression, and inhibited its transactivation, leading to the downregulation of the PXR-regulated CYP3A29 expression. Furthermore, cecropin B activated pig liver cells by interacting with TLRs 2 and 4, which modulated NF-κB-mediated signaling pathways. In conclusion, cecropin B inhibited the expression of CYP3A29 in a TLR/NF-κB/PXR-dependent manner, which should be considered in future development of cecropins and other antimicrobial peptides.
Insights
Cecropin B peptide antibiotics inhibit CYP3A29 expression by activating Toll-like receptors (TLRs) and NF-κB signaling. This pathway disrupts PXR/RXR-α complex binding, downregulating CYP3A29.
Area of Science:
- Pharmacology
- Molecular Biology
- Immunology
Background:
- Cecropins are peptide antibiotics with applications as drugs and feed additives.
- Cecropin B is known to inhibit CYP3A29 expression, but the mechanism is not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms by which cecropin B affects CYP3A29 expression.
- To investigate the roles of Toll-like receptors (TLRs) and NF-κB pathways in this process.
Main Methods:
- Investigated the effects of cecropin B on CYP3A29 expression in pig liver cells.
- Analyzed the involvement of pregnane X receptor (PXR), retinoid X receptor alpha (RXR-α), and NF-κB signaling.
- Examined the interaction of cecropin B with TLRs 2 and 4.
Main Results:
- Cecropin B dose- and time-dependently inhibited CYP3A29 expression.
- NF-κB activation by cecropin B disrupted the PXR/RXR-α complex binding to DNA.
- NF-κB p65 directly interacted with PXR, suppressing its transactivation and leading to CYP3A29 downregulation.
- Cecropin B activated TLRs 2 and 4, modulating NF-κB signaling.
Conclusions:
- Cecropin B inhibits CYP3A29 expression through a TLR/NF-κB/PXR-dependent pathway.
- These findings are crucial for the future development of cecropins and other antimicrobial peptides.
More Related Videos
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Related Concept Videos
Cell Specific Gene Expression
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Repressible Operon: trp Operon
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
GPCR Desensitization